Merck & Co. Inc.

NYSE: MRK · Real-Time Price · USD
83.95
1.19 (1.44%)
At close: Aug 15, 2025, 9:57 AM

Merck & Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
17.13B 365M 14.53B 12.36B
Depreciation & Amortization
4.5B 3.87B 3.91B 3.21B
Stock-Based Compensation
761M 645M 541M 479M
Other Working Capital
-2.77B 139M -1.69B -1.54B
Other Non-Cash Items
3.99B 12.23B 4.47B 1.71B
Deferred Income Tax
-1.25B -1.9B -1.57B 187M
Change in Working Capital
-3.67B -2.21B -2.78B -3.84B
Operating Cash Flow
21.47B 13.01B 19.09B 14.11B
Capital Expenditures
-3.37B -3.86B -4.39B -4.45B
Cash Acquisitions
-4.09B -12.03B -121M -12.91B
Purchase of Investments
-519M -955M -1.2B -1M
Sales Maturities Of Investments
377M 1.66B 721M 1.03B
Other Investing Acitivies
-127M 1.11B 32M -225M
Investing Cash Flow
-7.73B -14.08B -4.96B -16.55B
Debt Repayment
2.31B 4.18B -2.25B 1.63B
Common Stock Repurchased
-1.31B -1.35B -384M -840M
Dividend Paid
-7.84B -7.45B -7.01B -6.61B
Other Financial Acitivies
-195M -203M 144M 8.41B
Financial Cash Flow
-7.03B -4.81B -9.12B 2.59B
Net Cash Flow
6.41B -5.86B 4.61B 14M
Free Cash Flow
18.1B 9.14B 14.71B 9.66B